Financial Highlights

Financial Highlights

2018 2017 2016
Revenue S$120.9m S$112.7m S$100.5m
EBITDA S$8.0m S$8.1m S$6.5m
Net Profit S$5.4m S$6.1m S$5.2m
EPS* 1.8 cents 2.0 cents 1.7 cents
NAV per share* 13.1 cents 6.3 cents 6.5 cents
Operating cash flow S$7.5m S$4.6m S$6.5m
Gearing ratio 7.7% 21.0% 36.9%
Dividends per share 0.55 cents

* For comparative purposes, EPS and NAV per share have been computed based on share capital of 300,000,000 shares assuming that the Restructuring Exercise and the issuance of 60,000,000 new shares pursuant to the IPO had been completed as at 1 January 2016.

Revenue by Business Segments

S$ million FY2018 FY2017 FY2016
Specialty pharma principals 69.4 60.7 51.9
Proprietary brands 13.2 12.4 10.9
Medical hypermart & digital 38.2 39.6 37.7
Total revenue 120.9 112.7 100.5

Revenue by Countries

S$ million FY2018 FY2017 FY2016
Singapore 53.9 54.8 51.8
Vietnam 52.7 46.9 38.5
Malaysia 7.6 5.3 4.8
Others 6.7 5.7 5.4
Total revenue 120.9 112.7 100.5